中国高校科技期刊研究会第9次会员代表大会在北京召开，中宣部出版局副局长张怀海、教育部科学技术与信息化司一级巡视员张国辉等领导出席会议并发表..
英文简介：Official Journal of the European Behavioural Pharmacology Society (EBPS)Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:Human Psychopharmacology: ExperimentalThis section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.Human Psychopharmacology: Clinical and TranslationalThis section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.Preclinical psychopharmacology: Behavioral and NeuralThis section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.Preclinical Psychopharmacology: TranslationalThis section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.Preclinical Psychopharmacology: Molecular, Genetic and EpigeneticThis section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.中文简介：（来自Google、百度翻译）欧洲行为药理学会 (EBPS) 官方杂志 心理药理学是一本国际期刊，涵盖了阐明药物影响行为的机制的广泛主题。该杂志的范围包括以下领域: 人类心理药理学: 实验 本节包括描述药物对人类情绪，行为，认知和生理的影响的手稿。该杂志鼓励涉及脑成像，遗传学，神经内分泌学和发育主题的论文。本节中的手稿通常描述在受控条件下进行的研究，但有时也会考虑描述性或观察性研究。 人类心理药理学: 临床和转化 本节包括针对药物和精神疾病广泛交叉的研究。这不仅包括药物使用和代谢，药物监测和药物流行病学的临床试验和研究，还包括利用整个临床相关方法的工作，包括神经影像学，药物遗传学，认知科学，生物标志物等。特别鼓励将临床前知识翻译为临床知识的工作。本节提交的主要特点是它们涉及临床方面的重点。 临床前心理药理学: 行为和神经 本节考虑有关具有定义的化学结构的化合物对行为的任何方面的影响的报告，特别是当与神经化学作用相关时，在人类以外的物种中。欢迎包含神经科学技术与行为相结合的手稿。我们鼓励在行为和分子水平上提供有关药物作用机制的研究报告。 临床前心理药理学: 翻译 本节考虑使用与疾病相关的临床前模型和测试来增强对中枢机制的信心的手稿，该机制可能对精神病患者或神经系统患者具有治疗价值，或者报告临床前操作和挑战有可能被翻译到临床。还将考虑基于临床发现 (反向翻译) 的旨在完善临床前模型的研究。该杂志特别鼓励整合目标组织暴露，分子靶标活性和/或目标生化途径调节的措施。 临床前心理药理学: 分子，遗传和表观遗传 本节重点介绍神经药理学药物/药物的分子和细胞作用，以及影响健康和疾病中枢神经系统的药物靶标的鉴定/验证。我们特别鼓励在分子水平上深入了解药物作用机制的研究。欢迎包含遗传或表观遗传对神经化学或行为影响的证据的手稿。
